KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Goodwill (2016 - 2025)

Historic Goodwill for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $8.3 billion.

  • Gilead Sciences' Goodwill changed 0.0% to $8.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $8.3 billion for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Gilead Sciences' Goodwill stood at $8.3 billion, which was down 0.0% from $8.3 billion recorded in Q2 2025.
  • Gilead Sciences' Goodwill's 5-year high stood at $8.3 billion during Q1 2021, with a 5-year trough of $8.3 billion in Q1 2022.
  • In the last 5 years, Gilead Sciences' Goodwill had a median value of $8.3 billion in 2022 and averaged $8.3 billion.
  • As far as peak fluctuations go, Gilead Sciences' Goodwill surged by 10242.9% in 2021, and later decreased by 24.0% in 2022.
  • Over the past 5 years, Gilead Sciences' Goodwill (Quarter) stood at $8.3 billion in 2021, then dropped by 0.22% to $8.3 billion in 2022, then changed by 0.0% to $8.3 billion in 2023, then changed by 0.0% to $8.3 billion in 2024, then changed by 0.0% to $8.3 billion in 2025.
  • Its last three reported values are $8.3 billion in Q3 2025, $8.3 billion for Q2 2025, and $8.3 billion during Q1 2025.